Youth marijuana use: State of the science for the practicing clinician

Current Opinion in Pediatrics

Volumn 26, Issue 4, 2014, Pages 420-427

  Hadland, Scott E ^a,b   Harris, Sion K ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adolescent; cannabis; drug abuse; marijuana abuse

Indexed keywords

DRONABINOL; ELECTRONIC CIGARETTE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ANXIETY; CANNABIS ADDICTION; CANNABIS USE; CANNABIS WITHDRAWAL SYNDROME; CARDIOVASCULAR FUNCTION; COGNITION; ENDOCRINE FUNCTION; GASTROINTESTINAL TRACT FUNCTION; HEALTH CARE POLICY; HUMAN; JUVENILE; LUNG FUNCTION; MENTAL HEALTH; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCREENING; SOCIAL PSYCHOLOGY; WITHDRAWAL SYNDROME; ATTENTION; ATTITUDE TO HEALTH; BRAIN; CARDIOVASCULAR SYSTEM; COMPLICATION; DIGESTIVE SYSTEM; DOSE RESPONSE; DRUG EFFECTS; ENDOCRINE SYSTEM; INFORMATION DISSEMINATION; INTELLIGENCE; LEARNING; MARIJUANA ABUSE; PATHOLOGY; PSYCHOLOGY; RESPIRATORY SYSTEM; SHORT TERM MEMORY; UNITED STATES;

ADOLESCENT; ADOLESCENT BEHAVIOR; ATTENTION; BRAIN; CARDIOVASCULAR SYSTEM; COGNITION; DIGESTIVE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE SYSTEM; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; INTELLIGENCE; LEARNING; MARIJUANA ABUSE; MEMORY, SHORT-TERM; RESPIRATORY SYSTEM; UNITED STATES;

EID: 84904465621     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000114     Document Type: Review

References (67)

1. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance-United States. MMWR Surveill Summ 2012; 61:1-162.
2. Johnston LD, O'Mally PM, Bachman JG, et al. Monitoring the future national results on drug use: 2013 overview, key findings on adolescent drug use. 2013. Available at http://www.monitoringthefuture.org/data/13data.html. [Accessed 30 December 2013]
3. SAMHSA. Results from the 2012 national survey on drug use and health: summary of national findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. 2013. Available at http://www.samhsa.gov/data/NSDUH/ 2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm. [Accessed 1 9 September 2013]
4. Hall W, Degenhardt L The adverse health effects of chronic cannabis use. Drug Test Anal 2014; 6:39-45.
5. Levy S. Effects of marijuana policy on children and adolescents. JAMA Pediatr 2013; 167:600-602.
6. Joffe A. Legalization of marijuana: potential impact on youth. Pediatrics 2004; 113:1825-1826. (Pubitemid 38698003)
7. AMA. H-95.998 AMA Policy Statement on Cannabis (Marijuana). 2012. Available at http://www.ama-assn.org/resources/doc/PolicyFinder/policy files/HnE/H-95.998.HTM. [Accessed 24 January 2014]
8. ASAM. White paper on state-level proposals to legalize marijuana. 2012. Available at http://www.asam.org/docs/publicy-policy-statements/state-level- proposals-to-legalize-marijuana-final2773DD668C2D.pdf. [Accessed 24 January 2014]
9. AACAP. AACAP Medical Marijuana Policy Statement. 2012. Available at http://www.aacap.org/AACAP/Policy-Statements/2012/AACAP-Medical- Marijuana-Policy-Statement.aspx. [Accessed 24 January 2014]
10. AECF. No place for kids: the case for reducing juvenile incarceration. 2011. Available at http://www.aecf.org/~/media/Pubs/Topics/Juvenile Justice/Detention Reform/NoPlaceForKids/JJ-NoPlaceForKids-Full.pdf. [Accessed 6 October 2013]
11. GCODP. War on drugs: report of the Global Commission on Drug Policy. 2011. Available at http://www.globalcommissionondrugs.org/wp-content/themes/ gcdp-v1/pdf/Global-Commission-Report-English.pdf. [Accessed 6 October 2013]
12. Werb D, Nosyk B, Kerr T, et al. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy. Int J Drug Policy 2012; 23:436-441.
13. Caulkins JP, Kilmer B, MacCoun RJ, et al. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19. Addiction 2012; 107:865-871.
14. Lynne-Landsman SD, Livingston MD, Wagenaar AC. Effects of state medical marijuana laws on adolescent marijuana use. Am J Public Health 2013;103:1500-1506.
15. UNODC. World drug report 2013. 2013. Available at http://www.unodc.org/ unodc/secured/wdr/wdr2013/World-Drug-Report-2013.pdf. [Accessed 7 October 2013]
16. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003; 42:327-360. (Pubitemid 36433875)
17. Harkany T, Guzman M, Hurd YL. Endocannabinoid functions in neurogenesis, neuronal migration, and specification. In: Köfalvi A, editor. Cannabinoids and the brain. New York, NY: Springer Science Business Media, LLC; 2008. pp. 237-256.
18. Mehmedic Z, Chandra S, Slade D, et al. Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 2010; 55:1209-1217.
19. Abrams DI, Vizoso HP, Shade SB, et al. Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther 2007; 82:572-578. (Pubitemid 47622524)
20. Sacco LN, Finklea K. Synthetic drugs: overview and issues for congress. 2013. Available at http://www.fas.org/sgp/crs/misc/R42066.pdf. [Accessed 7 October 2013]
21. Winstock AR, Ford C, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010; 340:c1571.
22. Bramness JG, Khiabani HZ, Morland J. Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction 2010; 105:1080-1087.
23. APA. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
24. Dennis M, Babor TF, Roebuck MC, et al. Changing the focus: the case for recognizing and treating cannabis use disorders. Addiction 2002; 97 (Suppl. 1):4-15. (Pubitemid 36013441)
25. SAMHSA. Treatment Episode Data Set (TEDS). Highlights-2007. National Admissions to Substance Abuse Treatment Services. DASIS Series: S-45, DHHS Publication No. (SMA) 09-4360. 2009. Available at http://wwwdasis. samhsa.gov/teds07/tedshigh2k7.pdf. [Accessed 19 September 2013]
26. Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007; 167:221-228.
27. Mehra R, Moore BA, Crothers K, et al. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006; 166:1359-1367. (Pubitemid 44036347)
28. Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012; 307:173-181.
29. Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008; 21:494-502.
30. Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014; 113:187-190.
31. Mukamal KJ, Maclure M, Muller JE, et al. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008; 155:465-470.
32. Gorzalka BB, Dang SS. Minireview: endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology 2012; 153:1016-1024.
33. Smith AM, Ferris JA, Simpson JM, et al. Cannabis use and sexual health. J Sex Med 2010; 7 (2 Pt 1):787-793.
34. Simonetto DA, Oxentenko AS, Herman ML, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012; 87:114-119.
35. Medina KL, Hanson KL, Schweinsburg AD, et al. Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc 2007; 13:807-820. (Pubitemid 47299450)
36. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012; 344:e536.
37. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 2012; 109:E2657-E2664.
38. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370:319-328. (Pubitemid 47094993)
39. Manrique-Garcia E, Zammit S, Dalman C, et al. Cannabis, schizophrenia and other nonaffective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med 2012; 42:1321-1328.
40. Horwood LJ, Fergusson DM, Coffey C, et al. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend 2012; 126:369-378.
41. Rasic D, Weerasinghe S, Asbridge M, et al. Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students. Drug Alcohol Depend 2013; 129:49-53.
42. Degenhardt L, Coffey C, Romaniuk H, et al. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 2013; 108:124-133.
43. Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000; 95:1621-1630.
44. Arria AM, Garnier-Dykstra LM, Cook ET, et al. Drug use patterns in young adulthood and postcollege employment. Drug Alcohol Depend 2013; 127:23-30.
45. Hara M, Huang DY, Weiss RE, et al. Concurrent life-course trajectories of employment and marijuana-use: exploring interdependence of longitudinal outcomes. J Subst Abuse Treat 2013; 45:426-432.
46. Hyggen C. Does smoking cannabis affect work commitment? Addiction 2012; 107:1309-1315.
47. Wagner FA, Anthony JC. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol 2002; 155:918-925. (Pubitemid 34517848)
48. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med 2013; 126:583-589.
49. Crean RD, Crane NA, Mason BJ.An evidencebasedreviewof acute and longterm effects of cannabis use on executive cognitive functions. J Addict Med 2011; 5:1-8.
50. Huestis MA, Mazzoni I, Rabin O. Cannabis in sport: antidoping perspective. Sports Med 2011; 41:949-966.
51. SADD LM. Hazy logic: Liberty Mutual Insurance/SADD Study finds driving under the influence of marijuana a greater threat to teen drivers than alcohol. 2012. Available at: http://www.sadd.org/press/presspdfs/Marijuana Teen Release.pdf. [Accessed 30 December 2013]
52. Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology 2012; 37:2368-2376.
53. Zalesky A, Solowij N, Yucel M, et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain 2012; 135:2245-2255.
54. Swift W, Coffey C, Degenhardt L, et al. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study. J Epidemiol Community Health 2012; 66:e26.
55. Hagan JF, Shaw JS, Duncan PM. Bright futures: guidelines for health supervision of infants, children and adolescents. 3rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2008.
56. Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med 2002; 156:607-614. (Pubitemid 34596192)
57. Brooks T, Knight JR. Screening and brief intervention for adolescents. In: Ries RC, Miller SA, Saitz R, editors. Addiction medicine. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014.
58. Levy SJ, Kokotailo PK. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics 2011; 128:e1330-e1340.
59. Denis C, Lavie E, Fatseas M, et al. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Syst Rev 2006; CD005336.
60. Hoch E, Buhringer G, Pixa A, et al. CANDIS treatment program for cannabis use disorders: findings from a randomized multisite translational trial. Drug Alcohol Depend 2014; 134:185-193.
61. Levin FR, Mariani JJ, Brooks DJ, et al. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 2011; 116:142-150.
62. McRae-Clark AL, Carter RE, Killeen TK, et al. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend 2009; 105:132-138.
63. Gray KM, Carpenter MJ, Baker NL, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry 2012; 169:805-812.
64. Mason BJ, Crean R, Goodell V, et al. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 2012; 37:1689-1698.
65. Weinstein AM, Miller H, Bluvstein I, et al. Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a doubleblind placebo-controlled study. Am J Drug Alcohol Abuse 2014; 40:16-22.
66. Gates P, Copeland J, Swift W, et al. Barriers and facilitators to cannabis treatment. Drug Alcohol Rev 2012; 31:311-319.
67. Rooke S, Copeland J, Norberg M, et al. Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial. J Med Internet Res 2013; 15:e26.